La descarga está en progreso. Por favor, espere

La descarga está en progreso. Por favor, espere

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome by Alejandra Martínez-Trillos, Magda.

Publicada porAlejandra Araya Soler Modificado hace 9 años

Presentaciones similares

Presentación del tema: "Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome by Alejandra Martínez-Trillos, Magda."— Transcripción de la presentación:

1 Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome by Alejandra Martínez-Trillos, Magda Pinyol, Alba Navarro, Marta Aymerich, Pedro Jares, Manel Juan, María Rozman, Dolors Colomer, Julio Delgado, Eva Giné, Marcos González-Díaz, Jesús M. Hernández-Rivas, Enrique Colado, Consolación Rayón, Angel R. Payer, Maria José Terol, Blanca Navarro, Victor Quesada, Xosé S. Puente, Ciril Rozman, Carlos López-Otín, Elías Campo, Armando López-Guillermo, and Neus Villamor Blood Volume 123(24):3790-3796 June 12, 2014 ©2014 by American Society of Hematology

2 Age distribution and outcome of patients according to TLR/MYD88 mutations. Alejandra Martínez-Trillos et al. Blood 2014;123:3790-3796 ©2014 by American Society of Hematology

3 Distribution of gene mutations according to age and outcome of CLL patients age ≤50 years according to TLR/MYD88. Alejandra Martínez-Trillos et al. Blood 2014;123:3790-3796 ©2014 by American Society of Hematology

Descargar ppt "Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome by Alejandra Martínez-Trillos, Magda."

Presentaciones similares

Vamos a jugar “¿Dónde está el tesoro?” ¿Dónde está el tesoro? El tesoro está __________ en la Florida.

Vamos a jugar “¿Dónde está el tesoro?” ¿Dónde está el tesoro? El tesoro está __________ en la Florida.
Vamos a jugar “¿Dónde está el tesoro?” ¿Dónde está el tesoro? El tesoro está __________ en México.

Vamos a jugar “¿Dónde está el tesoro?” ¿Dónde está el tesoro? El tesoro está __________ en México.
Banderas del Caribe.

Banderas del Caribe.
Jornadas de actualización en LMA

Jornadas de actualización en LMA
Banderas de América Central (Colores y Figuras)

Banderas de América Central (Colores y Figuras)
Banderas de América del Sur (Colores y Figuras)

Banderas de América del Sur (Colores y Figuras)
Español 1 J. Payano, E. Dominicci

Español 1 J. Payano, E. Dominicci
Así se dice My name is ________________________ I am _____________________________ And you? What’s your name? __________ I’m from New York __________________.

Así se dice My name is ________________________ I am _____________________________ And you? What’s your name? __________ I’m from New York __________________.
Warm Up Spanish I Marta Raúl y yo El profesor Carmona José y Elisa

Warm Up Spanish I Marta Raúl y yo El profesor Carmona José y Elisa
Objectives: To recognize family relationships To identify people by name and family relationship. To ask and tell classmates the names of their family.

Objectives: To recognize family relationships To identify people by name and family relationship. To ask and tell classmates the names of their family.
Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant Diego Penela, MD, Juan Acosta,

Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant Diego Penela, MD, Juan Acosta,
Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome by Paloma Ibarrondo, Andres Insunza, Sonia González de Villambrosia, María José.

Prognostic Value of Chromosome 1 Abnormalities in Myelodysplastic Syndrome by Paloma Ibarrondo, Andres Insunza, Sonia González de Villambrosia, María José.
HLA-DRB1*15:01 allele protects from asthma susceptibility María Pino-Yanes, PhD, Almudena Corrales, CLT, Marialbert Acosta-Herrera, MSc, Eva Pérez-Rodríguez,

HLA-DRB1*15:01 allele protects from asthma susceptibility María Pino-Yanes, PhD, Almudena Corrales, CLT, Marialbert Acosta-Herrera, MSc, Eva Pérez-Rodríguez,
The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer Eva Ciruelos, Tomás Pascual, María Luisa.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer Eva Ciruelos, Tomás Pascual, María Luisa.
Study design for the “effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion” (METOCARD-CNIC): A randomized, controlled parallel-group,

Study design for the “effect of METOprolol in CARDioproteCtioN during an acute myocardial InfarCtion” (METOCARD-CNIC): A randomized, controlled parallel-group,
Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba,

Could Chronic Gvhd Overcome the Poor Prognosis of Patients with MDS and TP53 Undergoing Allogeneic HSCT? by Juan Carlos Caballero, Mercedes Sánchez-Barba,
Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality by Joaquín Martínez-López, Bruno.

Critical analysis of the stringent complete response in multiple myeloma: contribution of sFLC and bone marrow clonality by Joaquín Martínez-López, Bruno.
Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM by María-Victoria Mateos, Joaquín Martínez-López, Miguel-Teodoro.

Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MM by María-Victoria Mateos, Joaquín Martínez-López, Miguel-Teodoro.
Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Jesús María Hernández,

Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Jesús María Hernández,
Validation of the NCCN-IPI for Diffuse Large B-Cell Lymphoma (DLBCL) in a Nation-Wide Spanish Series of 1885 Patients. the Geltamo-IPI Project by Carlos.

Validation of the NCCN-IPI for Diffuse Large B-Cell Lymphoma (DLBCL) in a Nation-Wide Spanish Series of 1885 Patients. the Geltamo-IPI Project by Carlos.

Presentaciones similares

Anuncios Google